• Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends
Close Search
00
GBAF LogoGBAF Logo
  • Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends
GBAF Logo
  • Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Global Banking & Finance Review

Company

    GBAF Logo
    • About Us
    • Profile
    • Wealth
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2025 GBAF Publications Ltd - All Rights Reserved.

    ;
    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Research Reports

    Posted By mark itwired

    Posted on September 2, 2021

    Featured image for article about Research Reports

    Global vaginitis treatment market is set to reach USD 2.7 Bn in 2020, and witness a CAGR of around 5% during the forecast period (2020 – 2030). These insights are from a latest market research study by Future Market Insights (FMI), an ESOMAR-certified research and consulting firm.

    Vaginal infection impacts 40% of women across the globe. Moreover, majority of those infected are asymptomatic. As such, it becomes utterly difficult to keep a track of vaginitis and the treatment to be administered.

    The only way out in this regard turns out to be creating awareness about the factors that lead to vaginitis; so that even if major symptoms do not appear; women could at least seek medical advice regarding the same.

    Several government-funded and/or private organizations are emphasizing on educating the people regarding vaginitis and the due course of treatment. Oral medications are prevalent in the current scenario.

    For instance – DARE-BV1, a new thermosetting hydrogel amass with clindamycin phosphate 2% did receive QIDP (Qualified Infectious Disease Product) designation by US FDA in Aug 2019. The product came from Dare Bioscience, Inc. Such developments are expected to encourage the other players to come up with new products; thereby bolstering the vaginitis treatment drugs market.

    Request For Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11790

    Key Takeaways of Vaginitis Treatment Drugs Market Study

    • Nitroimidazole compound is the largest segment by drug type representing 44% of revenue share in the Vaginitis Treatment Drugs Market in 2019.
    • By the schedule of drug, prescription (Rx) drugs contributes for 3/4th of market value share. Over-the-counter drugs (OTC) is expected to grow at a higher growth rate in the forecast period
    • North America and East Asia collectively contributed for more than half of the market share in the Vaginitis Treatment Drugs Market in 2019 with North America holding a noteworthy market share.

    “Development of single-dose drugs, growing demand for over-the-counter medication, and increasing recurrence rate of vaginitis will boost the growth of the Vaginitis Treatment Drugs Market,” says the FMI Analyst.

    Partnerships and Collaborations Paving the Way for Vaginitis Treatment Drugs Market

    Partnership strengthens the drug portfolio, broadens the consumer base, and gives an impetus to research and development. For instance – in March 2018, Bayer thrush treatment Canesten partnered with sketch comedy group SketchShe and media agency PHD for a campaign which intended to reduce the stigma and embarrassment associated with the condition.

    This campaign did give the consumers a fair idea about the BQ (Behavioral Quotient) of both the companies; and also left a lasting impression in the consumers’ minds.

    Want more insights?

    Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global Vaginitis Treatment Drugs Market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provide compelling insights on Vaginitis Treatment Drugs Market on basis of drug type (nitroimidazole compound, lincosamide antibiotics, triazoles, imidazoles), indication (bacterial vaginitis, fungal vaginitis (yeast infection), trichomoniasis), route of administration (oral, cutaneous, vaginal), schedule of drug (prescription drugs (Rx), over-the-counter drugs (OTC)) distribution channels (hospital pharmacies, retail pharmacies, drug stores, mail order pharmacies) across seven major regions.

    Table of Content

    1. Executive Summary

        1.1. Global Market Outlook

        1.2. Demand Side Trends

        1.3. Supply Side Trends

        1.4. Analysis and Recommendations

    1. Market Overview

        2.1. Market Coverage / Taxonomy

        2.2. Market Definition / Scope / Limitations

    1. Key Market Trends

        3.1. Key Trends Impacting the Market

        3.2. Innovation / Development Trends

    1. Market Context

        4.1. Regulatory Scenario

        4.2. Pipeline Analysis

        4.3. Reimbursement Scenario by Region

        4.4. Disease Epidemiology by Region

    1. Market Background

        5.1. Macro-Economic Factors

        5.2. Forecast Factors – Relevance & Impact

        5.3. Market Dynamics

            5.3.1. Drivers

            5.3.2. Restraints

            5.3.3. Opportunity Analysis

        5.4. Value Chain Analysis

        5.5. COVID19 Crisis Analysis

            5.5.1. Current COVID19 Statistics and Probable Future Impact

            5.5.2. Current GDP Projection and Probable Impact

            5.5.3. Current Economic Projection as compared to 2008 Economic analysis

            5.5.4. COVID19 and Impact Analysis

                5.5.4.1. Revenue By Product

                5.5.4.2. Revenue By Country

            5.5.5. 2020 Market Scenario

            5.5.6. Quarter by Quarter Forecast

            5.5.7. Projected recovery Quarter

            5.5.8. Recovery Scenario – Short term, Midterm and Long Term Impact

    1. Global Vaginitis Treatment Drugs Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020–2030

        6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

        6.2. Current and Future Market Value (US$ Mn) Projections, 2020–2030

            6.2.1. Y-o-Y Growth Trend Analysis

            6.2.2. Absolute $ Opportunity Analysis

    The post Vaginitis Treatment Drugs Market Product by Demands, Size, Industry Share Growth and Forecast to 2030 first appeared on Market Research Blog.

    Global vaginitis treatment market is set to reach USD 2.7 Bn in 2020, and witness a CAGR of around 5% during the forecast period (2020 – 2030). These insights are from a latest market research study by Future Market Insights (FMI), an ESOMAR-certified research and consulting firm.

    Vaginal infection impacts 40% of women across the globe. Moreover, majority of those infected are asymptomatic. As such, it becomes utterly difficult to keep a track of vaginitis and the treatment to be administered.

    The only way out in this regard turns out to be creating awareness about the factors that lead to vaginitis; so that even if major symptoms do not appear; women could at least seek medical advice regarding the same.

    Several government-funded and/or private organizations are emphasizing on educating the people regarding vaginitis and the due course of treatment. Oral medications are prevalent in the current scenario.

    For instance – DARE-BV1, a new thermosetting hydrogel amass with clindamycin phosphate 2% did receive QIDP (Qualified Infectious Disease Product) designation by US FDA in Aug 2019. The product came from Dare Bioscience, Inc. Such developments are expected to encourage the other players to come up with new products; thereby bolstering the vaginitis treatment drugs market.

    Request For Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11790

    Key Takeaways of Vaginitis Treatment Drugs Market Study

    • Nitroimidazole compound is the largest segment by drug type representing 44% of revenue share in the Vaginitis Treatment Drugs Market in 2019.
    • By the schedule of drug, prescription (Rx) drugs contributes for 3/4th of market value share. Over-the-counter drugs (OTC) is expected to grow at a higher growth rate in the forecast period
    • North America and East Asia collectively contributed for more than half of the market share in the Vaginitis Treatment Drugs Market in 2019 with North America holding a noteworthy market share.

    “Development of single-dose drugs, growing demand for over-the-counter medication, and increasing recurrence rate of vaginitis will boost the growth of the Vaginitis Treatment Drugs Market,” says the FMI Analyst.

    Partnerships and Collaborations Paving the Way for Vaginitis Treatment Drugs Market

    Partnership strengthens the drug portfolio, broadens the consumer base, and gives an impetus to research and development. For instance – in March 2018, Bayer thrush treatment Canesten partnered with sketch comedy group SketchShe and media agency PHD for a campaign which intended to reduce the stigma and embarrassment associated with the condition.

    This campaign did give the consumers a fair idea about the BQ (Behavioral Quotient) of both the companies; and also left a lasting impression in the consumers’ minds.

    Want more insights?

    Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global Vaginitis Treatment Drugs Market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provide compelling insights on Vaginitis Treatment Drugs Market on basis of drug type (nitroimidazole compound, lincosamide antibiotics, triazoles, imidazoles), indication (bacterial vaginitis, fungal vaginitis (yeast infection), trichomoniasis), route of administration (oral, cutaneous, vaginal), schedule of drug (prescription drugs (Rx), over-the-counter drugs (OTC)) distribution channels (hospital pharmacies, retail pharmacies, drug stores, mail order pharmacies) across seven major regions.

    Table of Content

    1. Executive Summary

        1.1. Global Market Outlook

        1.2. Demand Side Trends

        1.3. Supply Side Trends

        1.4. Analysis and Recommendations

    1. Market Overview

        2.1. Market Coverage / Taxonomy

        2.2. Market Definition / Scope / Limitations

    1. Key Market Trends

        3.1. Key Trends Impacting the Market

        3.2. Innovation / Development Trends

    1. Market Context

        4.1. Regulatory Scenario

        4.2. Pipeline Analysis

        4.3. Reimbursement Scenario by Region

        4.4. Disease Epidemiology by Region

    1. Market Background

        5.1. Macro-Economic Factors

        5.2. Forecast Factors – Relevance & Impact

        5.3. Market Dynamics

            5.3.1. Drivers

            5.3.2. Restraints

            5.3.3. Opportunity Analysis

        5.4. Value Chain Analysis

        5.5. COVID19 Crisis Analysis

            5.5.1. Current COVID19 Statistics and Probable Future Impact

            5.5.2. Current GDP Projection and Probable Impact

            5.5.3. Current Economic Projection as compared to 2008 Economic analysis

            5.5.4. COVID19 and Impact Analysis

                5.5.4.1. Revenue By Product

                5.5.4.2. Revenue By Country

            5.5.5. 2020 Market Scenario

            5.5.6. Quarter by Quarter Forecast

            5.5.7. Projected recovery Quarter

            5.5.8. Recovery Scenario – Short term, Midterm and Long Term Impact

    1. Global Vaginitis Treatment Drugs Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020–2030

        6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

        6.2. Current and Future Market Value (US$ Mn) Projections, 2020–2030

            6.2.1. Y-o-Y Growth Trend Analysis

            6.2.2. Absolute $ Opportunity Analysis

    The post Vaginitis Treatment Drugs Market Product by Demands, Size, Industry Share Growth and Forecast to 2030 first appeared on Market Research Blog.

    Recommended for you

    • Thumbnail for recommended article

    • Thumbnail for recommended article

    • Thumbnail for recommended article

    Why waste money on news and opinions when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe